HK Stock MarketDetailed Quotes

00954 CHANGMAO BIO

Watchlist
  • 0.400
  • -0.005-1.23%
Market Closed Dec 27 16:08 CST
211.88MMarket Cap-1.78P/E (TTM)

CHANGMAO BIO Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
5.80%313.8M
-12.73%637.08M
-22.52%296.61M
33.22%730.03M
55.39%382.81M
23.39%547.98M
12.01%246.36M
-10.21%444.11M
-26.17%219.95M
-22.62%494.58M
Operating income
5.80%313.8M
-12.73%637.08M
-22.52%296.61M
33.22%730.03M
55.39%382.81M
23.39%547.98M
12.01%246.36M
-10.21%444.11M
-26.17%219.95M
-22.62%494.58M
Cost of sales
-16.73%-297.82M
-11.30%-611.27M
12.56%-255.14M
-7.84%-549.2M
-34.72%-291.8M
-46.07%-509.3M
-27.43%-216.6M
3.00%-348.66M
16.28%-169.98M
29.44%-359.43M
Operating expenses
-16.73%-297.82M
-11.30%-611.27M
12.56%-255.14M
-7.84%-549.2M
-34.72%-291.8M
-46.07%-509.3M
-27.43%-216.6M
3.00%-348.66M
16.28%-169.98M
29.44%-359.43M
Gross profit
-61.45%15.99M
-85.73%25.81M
-54.44%41.47M
367.51%180.83M
205.88%91.02M
-59.48%38.68M
-40.46%29.76M
-29.38%95.45M
-47.32%49.97M
4.18%135.16M
Selling expenses
-16.69%-4.19M
-3.18%-8.69M
-11.55%-3.59M
-2.57%-8.42M
5.98%-3.22M
-29.50%-8.21M
44.48%-3.43M
54.92%-6.34M
16.25%-6.17M
7.28%-14.06M
Administrative expenses
-5.25%-33.72M
15.73%-74.62M
22.35%-32.03M
-20.49%-88.55M
-40.83%-41.26M
-3.66%-73.49M
-18.65%-29.3M
-16.28%-70.89M
39.26%-24.69M
4.08%-60.96M
Impairment and provision
----
-234.56%-183K
----
585.71%136K
-98.91%2K
-123.33%-28K
88.66%183K
-65.12%120K
-54.88%97K
126.38%344K
-Other impairment is provision
----
-234.56%-183K
----
585.71%136K
-98.91%2K
-123.33%-28K
88.66%183K
-65.12%120K
-54.88%97K
126.38%344K
Special items of operating profit
155.86%7.35M
4.86%5.63M
7.28%2.87M
-95.83%5.37M
41.17%2.68M
9,702.68%128.87M
54.98%1.9M
-157.45%-1.34M
-40.70%1.22M
-59.41%2.34M
Operating profit
-267.21%-14.57M
-158.24%-52.05M
-82.29%8.72M
4.14%89.37M
5,642.34%49.22M
404.88%85.82M
-104.35%-888K
-72.94%17M
-58.41%20.43M
13.27%62.81M
Financing income
8.30%535K
11.81%1.05M
-3.52%494K
75.05%940K
63.06%512K
149.77%537K
220.41%314K
-18.56%215K
128.99%98K
-10.81%264K
Financing cost
-6.04%-3.41M
-184.11%-7.58M
-103.74%-3.21M
-36.73%-2.67M
-180.43%-1.58M
-3,048.39%-1.95M
-1,378.95%-562K
88.10%-62K
---38K
54.66%-521K
Earning before tax
-390.80%-17.44M
-166.84%-58.58M
-87.54%6M
3.83%87.64M
4,338.73%48.15M
392.12%84.41M
-105.54%-1.14M
-72.58%17.15M
-58.00%20.49M
14.56%62.55M
Tax
45.53%-1.13M
-344.45%-27.94M
72.23%-2.08M
76.01%-6.29M
-748.06%-7.5M
-6,306.36%-26.2M
120.99%1.16M
91.16%-409K
14.91%-5.51M
1.41%-4.63M
After-tax profit from continuing operations
-574.36%-18.58M
-206.34%-86.52M
-90.37%3.92M
39.77%81.36M
193,490.48%40.65M
247.65%58.21M
-99.86%21K
-71.10%16.74M
-64.59%14.98M
16.07%57.93M
Earning after tax
-574.36%-18.58M
-206.34%-86.52M
-90.37%3.92M
39.77%81.36M
193,490.48%40.65M
247.65%58.21M
-99.86%21K
-71.10%16.74M
-64.59%14.98M
16.07%57.93M
Minority profit
187.14%210K
-609.23%-461K
-6.64%-241K
41.44%-65K
-2.26%-226K
-32.14%-111K
-9.41%-221K
77.42%-84K
11.79%-202K
39.61%-372K
Profit attributable to shareholders
-551.91%-18.79M
-205.69%-86.06M
-89.83%4.16M
39.62%81.42M
16,792.56%40.88M
246.57%58.32M
-98.41%242K
-71.14%16.83M
-64.31%15.18M
15.39%58.3M
Basic earnings per share
-537.50%-0.035
-205.19%-0.162
-89.61%0.008
40.00%0.154
0.077
243.75%0.11
0
-70.91%0.032
-63.75%0.029
15.79%0.11
Diluted earnings per share
-537.50%-0.035
-205.19%-0.162
-89.61%0.008
40.00%0.154
0.077
243.75%0.11
0
-70.91%0.032
-63.75%0.029
15.79%0.11
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
PricewaterhouseCoopers
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover 5.80%313.8M-12.73%637.08M-22.52%296.61M33.22%730.03M55.39%382.81M23.39%547.98M12.01%246.36M-10.21%444.11M-26.17%219.95M-22.62%494.58M
Operating income 5.80%313.8M-12.73%637.08M-22.52%296.61M33.22%730.03M55.39%382.81M23.39%547.98M12.01%246.36M-10.21%444.11M-26.17%219.95M-22.62%494.58M
Cost of sales -16.73%-297.82M-11.30%-611.27M12.56%-255.14M-7.84%-549.2M-34.72%-291.8M-46.07%-509.3M-27.43%-216.6M3.00%-348.66M16.28%-169.98M29.44%-359.43M
Operating expenses -16.73%-297.82M-11.30%-611.27M12.56%-255.14M-7.84%-549.2M-34.72%-291.8M-46.07%-509.3M-27.43%-216.6M3.00%-348.66M16.28%-169.98M29.44%-359.43M
Gross profit -61.45%15.99M-85.73%25.81M-54.44%41.47M367.51%180.83M205.88%91.02M-59.48%38.68M-40.46%29.76M-29.38%95.45M-47.32%49.97M4.18%135.16M
Selling expenses -16.69%-4.19M-3.18%-8.69M-11.55%-3.59M-2.57%-8.42M5.98%-3.22M-29.50%-8.21M44.48%-3.43M54.92%-6.34M16.25%-6.17M7.28%-14.06M
Administrative expenses -5.25%-33.72M15.73%-74.62M22.35%-32.03M-20.49%-88.55M-40.83%-41.26M-3.66%-73.49M-18.65%-29.3M-16.28%-70.89M39.26%-24.69M4.08%-60.96M
Impairment and provision -----234.56%-183K----585.71%136K-98.91%2K-123.33%-28K88.66%183K-65.12%120K-54.88%97K126.38%344K
-Other impairment is provision -----234.56%-183K----585.71%136K-98.91%2K-123.33%-28K88.66%183K-65.12%120K-54.88%97K126.38%344K
Special items of operating profit 155.86%7.35M4.86%5.63M7.28%2.87M-95.83%5.37M41.17%2.68M9,702.68%128.87M54.98%1.9M-157.45%-1.34M-40.70%1.22M-59.41%2.34M
Operating profit -267.21%-14.57M-158.24%-52.05M-82.29%8.72M4.14%89.37M5,642.34%49.22M404.88%85.82M-104.35%-888K-72.94%17M-58.41%20.43M13.27%62.81M
Financing income 8.30%535K11.81%1.05M-3.52%494K75.05%940K63.06%512K149.77%537K220.41%314K-18.56%215K128.99%98K-10.81%264K
Financing cost -6.04%-3.41M-184.11%-7.58M-103.74%-3.21M-36.73%-2.67M-180.43%-1.58M-3,048.39%-1.95M-1,378.95%-562K88.10%-62K---38K54.66%-521K
Earning before tax -390.80%-17.44M-166.84%-58.58M-87.54%6M3.83%87.64M4,338.73%48.15M392.12%84.41M-105.54%-1.14M-72.58%17.15M-58.00%20.49M14.56%62.55M
Tax 45.53%-1.13M-344.45%-27.94M72.23%-2.08M76.01%-6.29M-748.06%-7.5M-6,306.36%-26.2M120.99%1.16M91.16%-409K14.91%-5.51M1.41%-4.63M
After-tax profit from continuing operations -574.36%-18.58M-206.34%-86.52M-90.37%3.92M39.77%81.36M193,490.48%40.65M247.65%58.21M-99.86%21K-71.10%16.74M-64.59%14.98M16.07%57.93M
Earning after tax -574.36%-18.58M-206.34%-86.52M-90.37%3.92M39.77%81.36M193,490.48%40.65M247.65%58.21M-99.86%21K-71.10%16.74M-64.59%14.98M16.07%57.93M
Minority profit 187.14%210K-609.23%-461K-6.64%-241K41.44%-65K-2.26%-226K-32.14%-111K-9.41%-221K77.42%-84K11.79%-202K39.61%-372K
Profit attributable to shareholders -551.91%-18.79M-205.69%-86.06M-89.83%4.16M39.62%81.42M16,792.56%40.88M246.57%58.32M-98.41%242K-71.14%16.83M-64.31%15.18M15.39%58.3M
Basic earnings per share -537.50%-0.035-205.19%-0.162-89.61%0.00840.00%0.1540.077243.75%0.110-70.91%0.032-63.75%0.02915.79%0.11
Diluted earnings per share -537.50%-0.035-205.19%-0.162-89.61%0.00840.00%0.1540.077243.75%0.110-70.91%0.032-63.75%0.02915.79%0.11
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)--PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)--PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)--PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)--PricewaterhouseCoopers

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending HK Stocks
HK Crypto ETF HK Crypto ETF

An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data. An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data.